Loading...
Docoh

China Botanic Pharmaceutical (CBPI)

We are a high-tech enterprise engaged in theresearch, development, manufacture, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines, or TCM, in the People’s Republic of China (“PRC” or “China”). We have three “Good Manufacturing Practice” or GMP certified production facilities - Ah City Natural and Biopharmaceutical plant, Dongfanghong pharmaceutical plant and Qingyang natural extraction plant -capable of producing 18 dosage forms and over 200 different products. Our products include but are not limited to (i) botanical anti-depression and nerve-regulation products, (ii) biopharmaceutical products, and (iii) botanical antibiotic and traditional over-the-counter (“OTC”) Chinese medicines. Botanical anti-depression and nerve-regulation products account for approximately 70% of our revenues and we intend to strengthen our development in this area. We have entered into sales agency agreements with our sales agents through them our products are sold to over 3,000 distributors and over 70 sales centers across 24 provinces in China.

Company profile

Ticker
CBPI
Exchange
Employees
Location
Fiscal year end
Former names
RENHUANG PHARMACEUTICALS INC, ANZA CAPITAL INC, E-NET FINANCIAL COM CORP
SEC CIK
IRS number
841273503

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

8 Jun 22
12 Aug 22
31 Oct 22
Quarter (USD) Apr 22 Jan 22 Oct 21 Jul 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Oct 21 Oct 20 Oct 13 Oct 12
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report)
Cash burn (monthly) (no burn) (no burn) 3.16K 29.47K 3.16K 8.64K
Cash used (since last report) n/a n/a 10.84K 101.16K 10.84K 29.65K
Cash remaining n/a n/a -10.84K -101.16K -10.84K -29.65K
Runway (months of cash) n/a n/a -3.4 -3.4 -3.4 -3.4

Beta Read what these cash burn values mean

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg